Liver diseases pose major problem in future for health care professionals: report

British Columbia needs more resources dedicated to the awareness, prevention and treatment of liver disease if it is to head off a brewing public health crisis, says one of the province’s leading liver specialists.

Dr. Eric Yoshida, head of the department of gastroenterology at the University of B.C. and an adviser to the Canadian Liver Foundation, said B.C. is already facing high personal and financial costs associated with liver diseases such as hepatitis B and C, cirrhosis and liver cancer.

“It’s a major problem,” said Yoshida Tuesday, the same day a report from the Canadian Liver Foundation warned liver disease is on the rise.

Deaths from liver disease increased by 30 per cent nationally in just eight years between 2000 and 2007. the report states, yet there is very little public awareness of the problem and no national strategy to address prevention and treatment.

“It is estimated that one in 10 Canadians, or more than three million people, has some form of liver disease,” says the report Liver Disease in Canada: A Crisis in the Making. B.C., Alberta, Ontario and Quebec stand to be hardest hit by the disease, the report adds.

According to the foundation, B.C. has the third-highest rate in Canada of chronic hepatitis B infection, despite a neonatal immunization program that inoculates children against the virus at birth, four weeks, and six months of age.

Read More

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below